Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Tenover

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
Journal of Clinical Microbiology|June 28, 2001
Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology networkL McGee, L McDougal, J Zhou, et al.
Journal of Clinical Microbiology|September 1, 1987
Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, WashingtonP A Totten, C M Patton, F C Tenover, et al.
Infection Control and Hospital Epidemiology|October 26, 1999
Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance systemZ F Dembek, S E Kellerman, L Ganley, et al.
The Journal of Infectious Diseases|November 1, 1991
gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and TennesseeC E Fasching, F C Tenover, T G Slama, et al.
Journal of Clinical Microbiology|July 1, 1994
Development of a standardized screening method for detection of vancomycin-resistant enterococciJ M Swenson, N C Clark, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18J K Rasheed, G J Anderson, H Yigit, et al.
Infection Control and Hospital Epidemiology|April 1, 1999
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidisD O Garrett, E Jochimsen, K Murfitt, et al.
Journal of Clinical Microbiology|September 15, 2004
Uses of Staphylococcus aureus GeneChips in genotyping and genetic composition analysisP M Dunman, W Mounts, F McAleese, et al.
Journal of Clinical Microbiology|May 23, 1998
Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptidesF C Tenover, M V Lancaster, B C Hill, et al.
Diagnostic Microbiology and Infectious Disease|February 11, 1992
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistanceH C Neu, R J Duma, R N Jones, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
Journal of Clinical Microbiology|June 28, 2001
Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology networkL McGee, L McDougal, J Zhou, et al.
Journal of Clinical Microbiology|September 1, 1987
Prevalence and characterization of hippurate-negative Campylobacter jejuni in King County, WashingtonP A Totten, C M Patton, F C Tenover, et al.
Infection Control and Hospital Epidemiology|October 26, 1999
Reporting of vancomycin-resistant enterococci in Connecticut: implementation and validation of a state-based surveillance systemZ F Dembek, S E Kellerman, L Ganley, et al.
The Journal of Infectious Diseases|November 1, 1991
gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and TennesseeC E Fasching, F C Tenover, T G Slama, et al.
Journal of Clinical Microbiology|July 1, 1994
Development of a standardized screening method for detection of vancomycin-resistant enterococciJ M Swenson, N C Clark, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18J K Rasheed, G J Anderson, H Yigit, et al.
Infection Control and Hospital Epidemiology|April 1, 1999
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidisD O Garrett, E Jochimsen, K Murfitt, et al.
Journal of Clinical Microbiology|September 15, 2004
Uses of Staphylococcus aureus GeneChips in genotyping and genetic composition analysisP M Dunman, W Mounts, F McAleese, et al.
Journal of Clinical Microbiology|May 23, 1998
Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptidesF C Tenover, M V Lancaster, B C Hill, et al.
Diagnostic Microbiology and Infectious Disease|February 11, 1992
Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistanceH C Neu, R J Duma, R N Jones, et al.
Pageof 20